AHR and cancer: Overexpression of IDO1 leads to increased production of KP metabolites in the local cancer microenvironment, and consequently activation of AHR, which results in initiation of tumorigenesis by suppressing antitumor immune responses and promoting tumor cell survival and motility (Figure 4).